Literature DB >> 363333

Metoprolol with and without chlorthalidone in hypertension.

M Kubik, M Kendall, A Ebbutt, V John.   

Abstract

After a control period on a placebo, 45 patients with mild to moderate hypertension were treated with metoprolol, 100 mg twice daily alone and in free combination with chlorthalidone 50 mg daily using a double-blind crossover technique. The beta-blocker alone induced a significant fall in blood pressure; the diastolic pressure was reduced to 100 mg Hg or less in 37 of the 45 patients and to 95 mm Hg or less in 19 patients. The addition of chlorthalidone enhanced the antihypertensive effect so that in 33 patients diastolic pressure fell to 95 mm Hg or less. The drugs were well tolerated even by a small number of patients with chronic bronchitis and diabetes mellitus. None of the patients developed cardiac failure. Adding a diuretic caused a small reduction in serum potassium concentrations, and the relevance of this observation is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 363333     DOI: 10.1002/cpt197925125

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.

Authors:  J Godbillon; A Gerardin; V A John; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  A naturalistic study of hypertension in a rural U.K. community. 2 Years results.

Authors:  P J Fell; J M Shakespeare; N P Watson; H F O'Donnell
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA)

Authors:  R C Browning; V A John; R J Till; W Theobald
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.